Skip to content

UIPL

Udruženje inovativnih proizvođača lijekova u BiH / Association of Research-Based Medicine Producers in Bosnia & Herzegovina

  • HOME
  • ABOUT US
    • STATUTE, CODE OF CONDUCT, CRITERIA
      • UIPL STATUTE
      • UIPL CODE OF CONDUCT
    • ETHICAL CONDUCT AND TRANSPARENCY IN OPERATIONS OF COMPANIES
      • 2019 DISCLOSURES
      • 2020 DISCLOSURES
      • 2021 DISCLOSURES
      • 2022 DISCLOSURES
      • 2024 DISCLOSURES
      • 2024 DISCLOSURES
  • NEWS
  • MEMBERS
  • GALLERY
  • RELEVANT INSTITUTIONS
  • EU4HEALTH – INFO
  • CONTACT
  • EnglishEnglish
    • BosanskiBosanski
    • EnglishEnglish
UIPL

Category: ETHICAL CONDUCT AND TRANSPARENCY IN OPERATIONS OF COMPANIES

UIPL members and producers of innovative medicines, in accordance with the Code of Conduct, are committed to public disclosure of the Transfer of Value to healthcare organizations and healthcare workers in Bosnia and Herzegovina.

The main goal of the public announcement of the Transfer of Value is to achieve greater transparency of the relationship between the pharmaceutical industry and health workers/organizations, to preserve and strengthen trust between doctors and pharmaceutical companies, and strengthen the reputation of the pharmaceutical industry and health workers.

Disclosures are listed below in chronological order.

2019

2020

2021

2022

2023

ETHICAL CONDUCT AND TRANSPARENCY IN OPERATIONS OF COMPANIES

2021 disclosures

Posted on October 5, 2021August 1, 2022

By CLICKING ON A COMPANY LINK you may access disclosures of transfers of value.          

ETHICAL CONDUCT AND TRANSPARENCY IN OPERATIONS OF COMPANIES

2020 disclosures

Posted on June 30, 2020June 30, 2023

   

  • BosanskiBosanski
  • EnglishEnglish
  • BosanskiBosanski
  • EnglishEnglish
© Copyright 2020 UIPL. Created by ZIDigital